Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer. Read more about Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer.
Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping Example. Read more about Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping Example.
A consensus platform for antibody characterization. Read more about A consensus platform for antibody characterization.
DARPins as a novel tool to detect and degrade p73. Read more about DARPins as a novel tool to detect and degrade p73.
Interplay between β-propeller subunits WDR26 and muskelin regulates the CTLH E3 ligase supramolecular complex. Read more about Interplay between β-propeller subunits WDR26 and muskelin regulates the CTLH E3 ligase supramolecular complex.
Probing the Protein Kinases' Cysteinome by Covalent Fragments. Read more about Probing the Protein Kinases' Cysteinome by Covalent Fragments.
Targeting Na(v)1.7 and Na(v)1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain. Read more about Targeting Na(v)1.7 and Na(v)1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain.
Development and Discovery of a Selective Degrader of Casein Kinases 1 δ/ε. Read more about Development and Discovery of a Selective Degrader of Casein Kinases 1 δ/ε.
Phenomics-based Discovery of Novel Orthosteric Choline Kinase Inhibitors. Read more about Phenomics-based Discovery of Novel Orthosteric Choline Kinase Inhibitors.
17.12.2024 Celebrating Excellence: How SGC Trainees Drive Innovation in Drug Discovery by: SGC Photo left to right: Johannes Dopfer (SGC-Frankfurt) and Jacob Capener (SGC-UNC).
